10-Q
Quarterly Report
Actuate Therapeutics, Inc.
ACTU
NASDAQ
CIK: 1652935
File #: 001-42139
Balance Sheet
34 line items · 2 periods
XBRL
| Item | Jun 30, 2024 | Dec 31, 2023 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 351,709 | 2,958,659 |
Other Non-Operating Current Assets | 197,978 | 36,907 |
Total current assets | 549,687 | 2,995,566 |
Other Non-Current Assets | 1,181,139 | 0 |
Total assets | 1,730,826 | 2,995,566 |
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT | ||
Current liabilities: | ||
Accounts Payable | 5,893,034 | 3,421,840 |
Other Current Liabilities | 277,500 | 277,500 |
Other Non-Operating Current Liabilities | 70,097 | 0 |
UIC License Agreement | 70,097 | — |
Other Non-Operating Current Liabilities | 6,932,367 | 3,221,254 |
Short-Term Debt | 6,900,000 | 0 |
Total current liabilities | 20,072,998 | 6,920,594 |
Long term liabilities: | ||
Other Non-Operating Non-Current Liabilities | 1,260,903 | 988,049 |
Other Non-Operating Current Liabilities | 70,096 | 130,041 |
UIC License Agreement | 140,193 | 130,041 |
Other Non-Operating Current Liabilities | 404,991 | 404,991 |
Total long-term liabilities | 1,735,990 | 1,523,081 |
Total liabilities | 21,808,988 | 8,443,675 |
Temporary Equity | 94,178,404 | 94,178,404 |
Stockholders’ deficit: | ||
Total Stockholders' Equity | 2 | 2 |
Total Stockholders' Equity | 5,706,231 | 5,468,006 |
Total Stockholders' Equity | (119,962,799) | (105,094,521) |
Total stockholders’ deficit | (114,256,566) | (99,626,513) |
Redeemable Convertible Preferred Stock | 94,178,404 | 94,178,404 |
Common Stock | 2 | 2 |
Additional Paid-in Capital | 5,706,231 | 5,468,006 |
Retained Earnings | (119,962,799) | (105,094,521) |
Total liabilities, redeemable convertible preferred stock and stockholders’ deficit | 1,730,826 | 2,995,566 |